Answers for the patients who wait the longest.
Specialist rare disease diagnostics — from a single drop of blood, collected at home,analysed by one of Europe’s most experienced rare disease laboratories.
No clinic visit required. EU-wide delivery. Results within 10 business days.
-
Laboratory Excellence
Powered by Masdiag — a registered medical laboratory in Warsaw with over 12 years of specialist experience and more than 500,000 DBS samples analysed.
-
Test From Home
Our dried blood spot (DBS) collection kits are delivered to your door. A simple fingertip prick is all that is needed — no hospital, no clinic, no waiting room.
-
Rare Disease Focus
We don’t do routine. Every test we offer is selected for its relevance to rare and ultra-rare inherited metabolic conditions — the diseases that are hardest to diagnose.
Why rarediagnostics.eu exists
What is a rare disease? A disease is classified as rare when it affects fewer than 1 in 2,000 people. Yet rare diseases are — collectively — far from rare. There are more than 7,000 known rare diseases, and together they affect an estimated 8 to 10% of the European population. That means tens of millions of people across the EU are living with a condition that most doctors will never encounter in their career.
The consequences of this are profound. Rare disease patients — and their families — frequently face years of uncertainty, misdiagnosis, and unanswered questions. The average patient waits 5 to 7 years before receiving a correct diagnosis. This is not a failure of goodwill. It is a consequence of limited medical knowledge, insufficient diagnostic tools, and healthcare systems that are simply not designed with rare diseases in mind.
Patients with rare diseases are too often left outside the system — not because nobody cares, but because the knowledge and the tools to help them have not been accessible enough.
That is what rarediagnostics.eu is here to change.
We offer specialist biochemical diagnostics — developed and validated by our laboratory in Warsaw over more than 12 years — directly to patients, families and clinicians across Europe. Using the dried blood spot (DBS) method, we remove the barriers of geography, complexity and access. Your sample travels to us. Your results come back to you. And with the right diagnosis, the right care can finally begin.
Our diagnostic tests
All tests use dried blood spot (DBS) collection — a simple, minimally invasive method suitable for all ages including newborns.
-
3-O-Methyldopa (3-OMD) — Dried Blood Spot Test
Regular price €60,00 EURRegular priceSale price €60,00 EURSold out -
Acylcarnitine Profile — Dried Blood Spot Test
Regular price €130,00 EURRegular priceSale price €130,00 EURSold out -
LPC Derivatives of Very Long-Chain Fatty Acids (VLCFA) — Dried Blood Spot Test
Regular price €130,00 EURRegular priceSale price €130,00 EURSold out -
Amino Acid Profile — Dried Blood Spot Test
Regular price €70,00 EURRegular priceSale price €70,00 EURSold out
What is a dried blood spot test?
A dried blood spot (DBS) is collected by pricking the fingertip with a small lancet — the same technique used in national newborn screening programmes across Europe. A few drops of blood are placed on a filter paper card, allowed to dry, and sent to our laboratory by post.
No refrigeration. No courier. No clinic appointment. It is one of the most powerful tools in rare disease diagnostics — and we have been working with it since 2012.
Rare diseases are more common than you think
-
7,000+
Known rare diseases
-
8–10%
Of Europeans affected
-
5–7 years
Average diagnostic delay
-
500,000+
DBS samples analysed by our laboratory
Our mission is to help reduce that 5–7 year wait — one test at a time.
Who we work with
-
For patients and families:
Explore our testsIf you are living with a rare metabolic condition — or searching for a diagnosis — our tests offer a precise, accessible path forward. Order directly, collect at home, and share your results with your specialist.
-
For clinicians and researchers:
Contact usWe work with metabolic physicians, clinical geneticists, neurologists, and academic research institutions across Europe and beyond. Institutional ordering and research collaboration enquiries are welcome.